SomaLogic significantly expands key strategic collaboration with Novartis

Ten-year agreement with Novartis demonstrates broad and deep commitment to accelerating disease and therapeutic-specific insights based on proprietary proteomic technology Boulder, Colo., USA — SomaLo...

Learn More

Regulatory Affairs Professionals Society (RAPS) Welcomes New RAPS Colorado Chapter

Rockville, MD, USA, Oct. 17, 2019 (GLOBE NEWSWIRE)  The Regulatory Affairs Professionals Society (RAPS) announced the official launch of the RAPS Colorado Chapter. The group first began as a RAPS...

Learn More

Securisyn Medical Receives FDA 510(k) Clearance for its SolidAIRity™ III Airway Stabilization System

HIGHLANDS RANCH – October 9, 2019 – Securisyn Medical, LLC, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its SolidAIRity™ III Airw...

Learn More

IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures

IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures Funding will Advance Lead Drug in Type 1 Diabetes and Develop HLA-Targeted Therapeutic Platform in Autoimm...

Learn More

AmideBio Awarded SBIR Phase II Grant to Further Development of its Novel Glucagons for the Treatment of Hyperinsulinism

BOULDER, CO, September 30, 2019 – AmideBio, LLC, a privately held biopharmaceutical company, announced today that it has received $1.56M in funding through a Phase II Small Business Innovation Researc...

Learn More

GREFFEX, Inc. Awarded $18.7 Million Contract with NIH to Develop a Plug-and-Play Technology Platform to Expedite Production of Vaccine Candidates for Biodefense and Emerging Infectious Diseases

GREFFEX, Inc. (Aurora, CO), a Fitzsimons Innovation Community company, is a transformative leader in genetic engineering. The company was recently awarded an $18.7 million contract with the National I...

Learn More

Weekly Policy Update: CBSA Submits Comment Letter to CMS Advocating for Patient Access to Timely Precision Diagnostic Information

In July the Centers for Medicare and Medicaid Services (CMS) issued the CY 2020 Hospital Outpatient Prospective Payment System (HOPPS) Proposed Rule, which included concerning proposed revisions to th...

Learn More

Boulder Based Edgewise Therapeutics Closes $50 Million Series B Financing

Financing to Support Advancing Company’s Lead Product Candidate for Muscular Dystrophy- Boulder, Colo., (September 17, 2019) – Edgewise Therapeutics, a preclinical company developing small molecule th...

Learn More

Nymbl Science Releases Their August Update

Below please find an overview of our progress for the month of August: • We continue to move forward towards closing out our round. We have about $235k remaining with 4 angel pitches lined up in the n...

Learn More

Denver Business Journal Highlights Colorado’s Life Sciences Ecosystem and Our Leadership In Gene Editing

Gene editing is becoming an increasingly common remedy for a variety of ailments, and Boulder area bioscience companies are leading those advancements. Building on research and technology originating...

Learn More